Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Nucl Med Commun. 2012 Apr;33(4):349–361. doi: 10.1097/MNM.0b013e32834ec8a5

Figure 7.

Figure 7

Whole body PET MR performed on the Siemens whole body mMR MR/PET scanner ~4 hours following administration of 3.3mCi of 18F-NaF in a 63 year old patient with prostate cancer (Gleason 3+4). This study shows increased bony turnover in the mid-T-spine (SUV =29.7) in a location consistent with degenerative change. No bony metastatic disease was detected. Whole body coronal STIR MR sequence is shown.